Literature DB >> 11838324

Update on the cardiometabolic syndrome.

J R Sowers1.   

Abstract

An array of metabolic, hemodynamic, and renal abnormalities constitutes the cardiometabolic syndrome. A hallmark of this syndrome is visceral obesity and associated insulin resistance/hyperinsulinemia. The syndrome is also associated with essential hypertension, abnormalities in the circadian rhythm of blood pressure and heart rate, the diabetic dyslipidemic syndrome, hypercoagulability, hyperuricemia, increased cardiovascular inflammation, and microalbuminuria, all of which contribute to an increased risk of cardiovascular disease morbidity and mortality. This article reviews current knowledge about the interrelationship of the various factors that make up the cardiometabolic syndrome and its implications for individuals with and without diabetes mellitus.

Entities:  

Mesh:

Year:  2001        PMID: 11838324     DOI: 10.1016/s1098-3597(01)90026-2

Source DB:  PubMed          Journal:  Clin Cornerstone        ISSN: 1873-4480


  12 in total

Review 1.  Healthy weight - healthy blood pressure.

Authors:  Arun Chockalingam
Journal:  Can J Cardiol       Date:  2010-05       Impact factor: 5.223

2.  Fasting Triglyceride Concentrations are Associated with Early Mortality Following Antiretroviral Therapy in Zambia.

Authors:  Julius N Ngu; Douglas C Heimburger; Donna K Arnett; Christopher K Nyirenda; Dara Potter; Isaac Zulu; Claire N Bosire; Shashwatee Bagchi; Jiatao Ye; Benjamin H Chi; Edmond K Kabagambe
Journal:  N Am J Med Sci (Boston)       Date:  2010

3.  COVID-19: A Personalized Cardiometabolic Approach for Reducing Complications and Costs. The Role of Aging Beyond Topics.

Authors:  J Saban-Ruiz; D Ly-Pen
Journal:  J Nutr Health Aging       Date:  2020-05-12       Impact factor: 4.075

4.  Metabolic effects of fluvastatin extended release 80 mg and atorvastatin 20 mg in patients with type 2 diabetes mellitus and low serum high-density lipoprotein cholesterol levels: a 4-month, prospective, open-label, randomized, blinded-end point (probe) trial.

Authors:  Maurizio Bevilacqua; Barbara Guazzini; Velella Righini; Massimo Barrella; Rosanna Toscano; Enrica Chebat
Journal:  Curr Ther Res Clin Exp       Date:  2004-07

Review 5.  Cardiometabolic syndrome: pathophysiology and treatment.

Authors:  Jonathan P Castro; Fadi A El-Atat; Samy I McFarlane; Ashish Aneja; James R Sowers
Journal:  Curr Hypertens Rep       Date:  2003-10       Impact factor: 5.369

Review 6.  What is the relationship between exercise and metabolic abnormalities? A review of the metabolic syndrome.

Authors:  Sean Carroll; Mike Dudfield
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

Review 7.  Emerging issues for our nation's health: the intersection of marijuana use and cardiometabolic disease risk.

Authors:  Denise C Vidot; Guillermo Prado; WayWay M Hlaing; Kristopher L Arheart; Sarah E Messiah
Journal:  J Addict Dis       Date:  2014

8.  Anthropometry measures and prevalence of obesity in the urban adult population of Cameroon: an update from the Cameroon Burden of Diabetes Baseline Survey.

Authors:  Raoul M Kamadjeu; Richard Edwards; Joseph S Atanga; Emmanuel C Kiawi; Nigel Unwin; Jean-Claude Mbanya
Journal:  BMC Public Health       Date:  2006-09-13       Impact factor: 3.295

9.  Intimal redox stress: accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy.

Authors:  Melvin R Hayden; Suresh C Tyagi
Journal:  Cardiovasc Diabetol       Date:  2002-09-27       Impact factor: 9.951

10.  Anti-obesity activity of chloroform-methanol extract of Premna integrifolia in mice fed with cafeteria diet.

Authors:  Prashant Y Mali; Papiya Bigoniya; Shital S Panchal; Irrappa S Muchhandi
Journal:  J Pharm Bioallied Sci       Date:  2013-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.